Long-term, low-dose aspirin use linked to reduced risk of cancer death, study finds

Americans who use Aspirin are less likely to die from cancer, according to a recent study.

Sign up for our FREE E-Weekly for more coverage like this sent to your inbox!

For the study, researchers examined data on 86,206 women compiled in the Nurses' Health Study between 1980 and 2012, as well as data on 43,977 men compiled in the Health Professionals Follow-up Study between 1986 and 2012. Participants with a history of heart disease, stroke or cancer were excluded from the analysis.

More than 22,000 women and more than 14,700 men died over the course of the study period, and cancer was the cause of death for 8,271 women and 4,591 men, the analysis found. The analysis also revealed participants who regularly used aspirin were less likely to die than those who did not. Researchers determined the overall reduced risk of death was primarily attributable to a lower risk of death from cancer.

Overall, women who regularly used aspirin were 7 percent less likely to die than those who did not, compared to 11 percent for men who regularly used aspirin, according to CNN. Specifically, women who regularly used aspirin were 7 percent less likely to die from cancer than those who did not, compared to 15 percent for men who regularly used aspirin, according to the report.

Regular aspirin users were particularly less likely to die from colorectal cancer (men and women), breast cancer (women), prostate cancer (men) and lung cancer in men.

 

 

 

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Whitepapers

Featured Webinars